Mark L. Richards

1.3k total citations
32 papers, 1.1k citations indexed

About

Mark L. Richards is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark L. Richards has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Immunology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark L. Richards's work include Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Mark L. Richards is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Mark L. Richards collaborates with scholars based in United States, United Kingdom and Germany. Mark L. Richards's co-authors include Wolfgang Sadée, D H Katz, Victor C. Yu, Philipp Yu, Marinus C. Lamers, Georges Köhler, Marie Kosco‐Vilbois, James A. Waschek, Dawn T. Bravo and Anjana Sinha and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Mark L. Richards

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark L. Richards United States 20 510 366 315 181 149 32 1.1k
Kazumi Hayashi Japan 14 521 1.0× 157 0.4× 172 0.5× 85 0.5× 66 0.4× 33 958
Marco Trinchera Italy 23 1.2k 2.4× 59 0.2× 383 1.2× 251 1.4× 128 0.9× 54 1.4k
Pui Seto United States 20 710 1.4× 241 0.7× 413 1.3× 214 1.2× 439 2.9× 32 1.6k
Jerry Di Salvo United States 16 514 1.0× 170 0.5× 164 0.5× 83 0.5× 67 0.4× 28 970
Corinne Leprince France 16 558 1.1× 66 0.2× 373 1.2× 97 0.5× 132 0.9× 28 1.1k
Orie Tajima Japan 21 831 1.6× 81 0.2× 306 1.0× 239 1.3× 39 0.3× 38 1.1k
Michele Pallaoro Italy 10 1.2k 2.4× 108 0.3× 246 0.8× 108 0.6× 41 0.3× 12 1.5k
Lindsey Needham United Kingdom 15 491 1.0× 95 0.3× 313 1.0× 235 1.3× 154 1.0× 24 1.1k
Ikuo Kawashima Japan 22 797 1.6× 116 0.3× 236 0.7× 514 2.8× 133 0.9× 41 1.3k
Venugopal D. Talkad United States 13 660 1.3× 116 0.3× 100 0.3× 228 1.3× 57 0.4× 14 1.0k

Countries citing papers authored by Mark L. Richards

Since Specialization
Citations

This map shows the geographic impact of Mark L. Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Richards more than expected).

Fields of papers citing papers by Mark L. Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Richards. The network helps show where Mark L. Richards may publish in the future.

Co-authorship network of co-authors of Mark L. Richards

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Richards. A scholar is included among the top collaborators of Mark L. Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Richards. Mark L. Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chatterjee, Arka, et al.. (2007). Disruption of Golgi processing by 2-phenyl benzimidazole analogs blocks cell proliferation and slows tumor growth. Cancer Chemotherapy and Pharmacology. 61(6). 1045–1058. 13 indexed citations
3.
Richards, Mark L., Anjana Sinha, Homayon Banie, et al.. (2006). Substituted 2-phenyl-benzimidazole derivatives: novel compounds that suppress key markers of allergy. European Journal of Medicinal Chemistry. 41(8). 950–969. 29 indexed citations
4.
Richards, Mark L., et al.. (2006). Targeting the Secretory Pathway for Anti-Inflammatory Drug Development. Current Topics in Medicinal Chemistry. 6(2). 165–178. 4 indexed citations
5.
Richards, Mark L. & D H Katz. (1997). Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc ε RII (CD23): comparison with the germline ε promoter. The Journal of Immunology. 158(1). 263–272. 37 indexed citations
6.
Alpini, Gianfranco, Shannon Glaser, Rebecca Rodgers, et al.. (1997). Gamma-interferon inhibits secretin-induced choleresis and cholangiocyte proliferation in a murine model of cirrhosis. Journal of Hepatology. 27(2). 371–380. 22 indexed citations
7.
Waschek, James A., Mark L. Richards, & Dawn T. Bravo. (1995). Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines. Cancer Letters. 92(2). 143–149. 50 indexed citations
8.
Waschek, James A., Dawn T. Bravo, & Mark L. Richards. (1995). High levels of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor mRNA expression in primary and tumor lymphoid cells. Regulatory Peptides. 60(2-3). 149–157. 22 indexed citations
9.
Yu, Philipp, Marie Kosco‐Vilbois, Mark L. Richards, Georges Köhler, & Marinus C. Lamers. (1994). Negative feedback regulation of IgE synthesis by murine CD23. Nature. 369(6483). 753–756. 194 indexed citations
10.
Robertson, Michael W., et al.. (1991). mRNA Variants Encoding Multiple Forms of the High-Affinity IgE Receptor Alpha Subunit in Transformed and Nontransformed Mast Cells. International Archives of Allergy and Immunology. 96(4). 289–295. 7 indexed citations
11.
Richards, Mark L., et al.. (1990). The induction of murine B cell Ia by IgE-antigen complexes is dependent on protein synthesis and preceded by class II mRNA accumulation. Cellular Immunology. 128(1). 198–208. 1 indexed citations
12.
Richards, Mark L. & D H Katz. (1990). The binding of IgE to murine Fc epsilon RII is calcium-dependent but not inhibited by carbohydrate.. The Journal of Immunology. 144(7). 2638–2646. 52 indexed citations
13.
Richards, Mark L., John F. Marcelletti, & David H. Katz. (1988). IgE-antigen complexes enhance Fc epsilon R and Ia expression by murine B lymphocytes.. The Journal of Experimental Medicine. 168(2). 571–587. 21 indexed citations
14.
Yu, Victor C., et al.. (1988). Differentiation of Human Neuroblastoma Cells: Marked Potentiation of Prostaglandin E‐Stimulated Accumulation of Cyclic AMP by Retinoic Acid. Journal of Neurochemistry. 51(6). 1892–1899. 52 indexed citations
15.
Richards, Mark L. & Wolfgang Sadée. (1986). Human neuroblastoma cell lines as models of catechol uptake. Brain Research. 384(1). 132–137. 50 indexed citations
16.
Richards, Mark L. & Wolfgang Sadée. (1985). Buprenorphine is an Antagonist at the ϰ Opioid Receptor. Pharmaceutical Research. 2(4). 178–181. 29 indexed citations
17.
Richards, Mark L. & Wolfgang Sadée. (1985). In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.. Journal of Pharmacology and Experimental Therapeutics. 233(2). 425–432. 13 indexed citations
18.
Grevel, Joachim, et al.. (1984). Radioreceptor Assay of Narcotic Analgesics in Serum. Pharmaceutical Research. 1(5). 209–214. 7 indexed citations
19.
Rosenbaum, Jan S., Nicholas H. G. Holford, Mark L. Richards, Rashid Aman, & Wolfgang Sadée. (1984). Discrimination of three types of opioid binding sites in rat brain in vivo.. Molecular Pharmacology. 25(2). 242–248. 22 indexed citations
20.
Kisilevsky, Robert, M. A. Axelrad, Sylvain Brunet, & Mark L. Richards. (1976). Effects of amyloid induction on plasma protein turnover, and its implication.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 83(2). 299–318. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazumi Hayashi Breakdown of academic impact, for papers by Marco Trinchera Breakdown of academic impact, for papers by Pui Seto Breakdown of academic impact, for papers by Jerry Di Salvo Breakdown of academic impact, for papers by Corinne Leprince Breakdown of academic impact, for papers by Orie Tajima Breakdown of academic impact, for papers by Michele Pallaoro Breakdown of academic impact, for papers by Lindsey Needham Breakdown of academic impact, for papers by Ikuo Kawashima Breakdown of academic impact, for papers by Venugopal D. Talkad
Rankless by CCL
2026